Precision for Medicine company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

precisionformedicine.com

Founded Year

2012

Stage

Other Investors | Alive

About Precision for Medicine

Precision for Medicine is a clinical research organization that specializes in clinical trial services, specialty lab services, translational science, clinical data management, Biostatistics, biomarker strategies, sample sourcing and storage, immune monitoring, and IVD development. It is based in Frederick, Maryland.

Precision for Medicine Headquarter Location

8425 Precision Way Suite M

Frederick, Maryland, 21701,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Precision for Medicine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Precision for Medicine is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

484 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

Precision for Medicine Patents

Precision for Medicine has filed 5 patents.

The 3 most popular patent topics include:

  • Immune system
  • Immunology
  • Molecular biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/27/2019

6/14/2022

Cell biology, Molecular biology, Fluid dynamics, Electromagnetism, Acoustics

Grant

Application Date

12/27/2019

Grant Date

6/14/2022

Title

Related Topics

Cell biology, Molecular biology, Fluid dynamics, Electromagnetism, Acoustics

Status

Grant

Latest Precision for Medicine News

05:45 ET Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2022: Advantages Offered, by Non-invasivene Appr...

Mar 11, 2022

News provided by Share this article Share this article The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets. By cancer type, the global market for circulating tumor cells diagnostics has been segmented into breast cancer, colorectal cancer and prostate cancer. The fast growth rate of the colorectal cancer segment is attributed to rapid rise in the incidence of colorectal cancer, especially young adults. The growing prevalence of cancer, as circulating tumor cells find their applications in the diagnosis of cancer and precision management; advancements in technologies such as NGS and immunofluorescence; and growing awareness about the novel diagnostic methods for cancers are all major factors that will boost market growth. Reasons for Doing this Study This study was conducted to provide detailed information regarding new developments, prognostic and clinical research testing for circulating tumor cells. There is an increasing need for new and innovative technologies in this area. This industry is experiencing tremendous growth; the use of new prognostic technologies based on circulating tumor cells has increased in the past few years. This study will increase awareness of current and emerging technologies and practices for cancer and cancer research, especially for prostate, breast and colorectal cancers. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market. This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics. Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems. For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation. Report Includes An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026 Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V. Key Topics Covered:

Precision for Medicine Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Precision for Medicine Rank

  • When was Precision for Medicine founded?

    Precision for Medicine was founded in 2012.

  • Where is Precision for Medicine's headquarters?

    Precision for Medicine's headquarters is located at 8425 Precision Way, Frederick.

  • What is Precision for Medicine's latest funding round?

    Precision for Medicine's latest funding round is Other Investors.

  • Who are the investors of Precision for Medicine?

    Investors of Precision for Medicine include Oak Investment Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.